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The effect of herpes virus infection on human
dermal microvascular endothelial cells and herpes-
virus-1-infected peripheral blood mononuclear cells
on human dermal microvascular endothelial cells
was studied as a model of herpes-associated
erythema multiforme. After infection of human der-
mal microvascular endothelial cells with native
herpes virus and overnight culture, 60%±90% of
human dermal microvascular endothelial cells
showed cytopathic effects. HLA class I molecules
and CD31 (PECAM-1) surface expression in herpes-
virus-infected endothelial cells were substantially
downregulated, whereas CD54 (ICAM-1) remained
unchanged. Cocultivation with herpes-virus-1-
infected peripheral blood mononuclear cells left
characteristic plaques on the human dermal micro-
vascular endothelial cell monolayer; however, very
few human dermal microvascular endothelial cells
(1%±3%) were infected. Adhesion molecule expres-
sion of human dermal microvascular endothelial cells
cocultivated with herpes-virus-infected peripheral
blood mononuclear cells demonstrated a 5-fold
increase in CD54 expression, a 2-fold increase in
HLA class I expression, but no change of CD31 by
¯uorescence-activated cell sorter analysis. Incubation
of human dermal microvascular endothelial cells
with ultraviolet-C irradiated herpes-virus-infected
peripheral blood mononuclear cells had no effect on
morphology or adhesion molecule expression levels.
Changes of adhesion molecule expression by direct
infection or cocultivation with peripheral blood
mononuclear cells (with native and ultraviolet-C
inactivated herpes virus infection) were also docu-
mented at the mRNA level. Adhesion assays demon-
strated an increased binding of herpes-virus-infected
peripheral blood mononuclear cells versus non-
infected peripheral blood mononuclear cells to non-
infected human dermal microvascular endothelial
cells. Our results suggest that incubation of herpes-
virus-infected peripheral blood mononuclear cells
with human dermal microvascular endothelial cells
induces signi®cant upregulation of CD54 and major
histocompatibility complex class I molecules in the
surrounding noninfected human dermal microvascu-
lar endothelial cells, which is associated with an
increased binding of peripheral blood mononuclear
cells. Our in vitro ®ndings may serve as a model for
herpes-associated erythema multiforme possibly
explaining the dermal in¯ammatory reaction seen in
that condition. Key words: adhesion molecules/erythema
multiforme/Herpes simplex virus type 1/human dermal
microvascular endothelial cells. J Invest Dermatol 116:150±
156, 2001
A
ccording to present classi®cation, the clinical spec-
trum of erythema multiforme comprises at least two
distinct subsets: the common herpes-simplex-asso-
ciated erythema multiforme (HAEM), and the
infrequent and severe Stevens±Johnson syndrome/
toxic epidermal necrolysis (SJS/TEN) that is most often related to
drug intolerance (Fritsch and Ruiz-Maldonado, 1999). Both share
two morphologic features: target lesions ± circular erythemas or
urticarial plaques with strikingly concentric features like blisters,
necrosis, and hemorrhage; and satellite cell (or more widespread)
necrosis of the epidermis. Both subsets are thought to result from a
cytotoxic immunologic attack on keratinocytes expressing non self-
antigens, but the precise pathomechanisms are unknown. HAEM is
characterized by a marked in¯ammatory in®ltrate of the papillary
dermis chie¯y composed of CD4+ T lymphocytes and monocytes
(Paquet and Pierard, 1997) and microvascular damage (Tonnesen
et al, 1983), whereas there is only little in¯ammation in SJS/TEN
(``silent dermis''). It thus appears that dermal vessels play an
important role in the genesis of HAEM but much less so in SJS/
TEN.
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The evidence linking herpes simplex virus (HSV) to HAEM is
compelling. Recurrent HAEM is preceded by clinical lesions of
recurrent HSV infection in about 80% of cases (Howland et al,
1984). HSV-speci®c antigens have been demonstrated in lesional
skin by immuno¯uorescence (Orton et al, 1984) and by
immunohistochemistry (MalmstroÈm et al, 1990). HSV-DNA has
been found in epidermal cells of HAEM lesions in up to 90% of
patients by in situ hybridization and polymerase chain reaction
(Miura et al, 1992; Brice et al, 1994; Imafuku et al, 1997), whereas
viable HSV cannot be recovered by culture (Miura et al, 1992).
Similarly, HSV-DNA is detectable in peripheral blood cells in up to
60% of HAEM patients (Brice et al, 1994), as it is in 20% of patients
with acute episodes of herpes labialis (Brice et al, 1992), but viable
HSV can be recovered from blood or peripheral blood cells by
culture only in exceptional cases, such as in immunocompromised
patients and neonates with generalized HSV infection (Kimura et al,
1991; Stanberry et al, 1994; James et al, 1996). It has therefore been
proposed that, in HAEM, HSV-DNA fragments, but not the whole
virus, may be transported via monocytes from areas of virus
replication to the skin where it may be found in keratinocytes
(Imafuku et al, 1997).
In this study, we hypothesized that, during episodes of HAEM,
HSV material is transported to the dermal microvasculature in
peripheral blood mononuclear cells (PBMC), which then adhere to
endothelial cells and, by upregulation of adhesion molecules,
induce the dermal in¯ammation characteristic for HAEM. In order
to investigate the possible pathomechanism involved we chose
cultured human dermal microvascular endothelial cells (HDMEC)
and in vitro HSV-1 infected PBMC as a model system.
MATERIALS AND METHODS
Most experiments described below were carried out in HDMEC at passages
three to six. For adhesion assays, we used HMEC-1 cells (an immortalized
HDMEC cell line, Ades et al, 1992). All experiments were repeated three
to six times.
HSV-1 HSV-1, strain Wal (SchroÈder et al, 1981), was grown in Vero
cells (ATCC CCL-81) in EMEM (PAA Laboratories, Linz, Austria)
containing 2% fetal bovine serum (FBS), 2 mM L-glutamine, and
antibiotics. Virus titers of supernatants were determined by a plaque assay
in Vero cells using serial 1:10 dilutions of supernatants. Supernatants used
for infection of cell cultures contained 106±107 plaque forming units per ml
of HSV-1. Inactivated HSV-1 was prepared by ultraviolet-C (UV-C)
irradiation of supernatants according to Hirayama et al (1998).
Isolation and culture of HDMEC HDMEC were isolated from
human foreskins from different donors as described previously (Hoffmann
et al, 1999). Brie¯y, foreskins were incubated overnight in 1.2 units per ml
dispase II (Boehringer, Mannheim, Germany) in Puck's salt solution (Sigma
Chemicals, Deisenhofen, Germany) at 4°C. After peeling off the epidermis,
HDMEC were prepared from the dermis and cultured in cell culture ¯asks
in endothelial cell basal medium (EBM; Clonetics, Germany)
supplemented with 10% normal human serum (Clonetics), 5 ng per ml
epidermal growth factor (Clonetics), 2 mM L-glutamine (Clonetics), 100 U
per ml penicillin, 100 mg per ml streptomycin, 250 mg per ml amphotericin
B (all from Sigma) and, during the ®rst two passages, 5 3 10±5 M dibutyryl
cAMP (Sigma). The cultures obtained consisted of 100% endothelial cells as
assessed by morphologic and immuno-histochemical criteria (Swerlick et al,
1991).
Isolation of PBMC PBMC were isolated from heparinized blood of
healthy adult volunteers by density gradient centrifugation with Ficoll-
Paque (Pharmacia, Uppsala, Sweden). PBMC were washed twice with
phosphate-buffered saline (PBS), resuspended in RPMI 1640 (PAA
Laboratories) supplemented with 2 mM L-glutamine and 10% FBS,
stimulated with 1 mg per ml phytohaemagglutinin (Sigma), and cultured
overnight in Te¯on jars (Savillex Corporation, Minnetonka, MN) to
prevent monocyte adhesion.
Infection of HDMEC with HSV-1 by direct inoculation HDMEC
cultures, at approximately 70%±80% con¯uence, were washed once with
sterile PBS and then inoculated with HSV-1 (native or UV-C inactivated)
enriched supernatants at a multiplicity of infection of 10±100. After 1 h
incubation at 37°C, supernatants were replaced by EBM supplemented
with 2% FBS. Cells were cultured overnight and then evaluated for
cytopathic effects and surface antigen expression as measured by
¯uorescence-activated cell sorter (FACS) analysis. The ratio of HSV-1
infected HDMEC was determined by FACS or by direct
immuno¯uorescence on microscopic slides, using a ¯uorescein
isothiocyanate (FITC) conjugated polyclonal rabbit anti-HSV-1 antibody
(Dako, Glostrup, Denmark), normal rabbit serum serving as control.
Expression of surface molecules was measured by FACS analysis (see
below).
Infection of PBMC with HSV-1 PBMC were washed and incubated
with HSV-1 (native or inactivated) supernatants at a multiplicity of
infection of 1±10 for 1 h. The supernatant was then replaced by RPMI
containing 2% FBS, and cells were cultured overnight. The ratio of HSV-1
infected PBMC was determined as detailed above. Expression of surface
molecules was measured by FACS analysis (see below).
Identi®cation of HSV-1 infected PBMC subpopulations PBMC
infected with HSV-1 were subjected to a double staining technique: cells
were washed twice with cold PBS and stained both with FITC-conjugated
anti-HSV-1 and phycoerythrin (PE)-conjugated monoclonal antibodies
against lymphocyte and monocyte markers (CD3, CD14, CD19; Becton
Dickinson). Non-infected PBMC and PBMC exposed to UV-C
inactivated HSV-1 served as controls.
Infection of HDMEC via HSV-1 infected PBMC HDMEC were
washed once with PBS and then incubated with HSV-1 infected PBMC
(2±20 PBMC per HDMEC) for 1 h. Subsequently, HDMEC were
thoroughly rinsed with cold PBS to remove PBMC. After overnight
culture in EBM containing 2% FBS, surface antigen expression was
measured by FACS analysis. The infection rate of HDMEC was measured
by FACS analysis or by direct immuno¯uorescence as above.
Flow cytometric analyses (FACS) of surface antigens The expres-
sion of several surface antigens (see below) was investigated by FACS
analysis (FACSCalibur, Becton Dickinson, Mountain View, CA) according
to standard procedures (Hoffmann et al, 1999). Measurements were
performed after overnight culture of HDMEC infected with HSV-1 by
direct inoculation and via infected PBMC; untreated HDMEC, HDMEC
exposed to inactivated HSV-1, and HDMEC incubated with untreated
PBMC or with PBMC exposed to inactivated HSV served as controls. In a
series of experiments, the surface expression of these molecules in directly
HSV-1 infected HDMEC was studied in a time sequence of 1, 3, 16, and
20 h.
Surface molecule expression in cytokine-treated HDMEC HDMEC
were infected with HSV-1 by direct inoculation. Virus supernatant was
then replaced by serum-free EBM containing interferon-g (IFN-g) (200 U
per ml), tumor necrosis factor a (TNF-a) (100 U per ml) (both from
Boehringer Mannheim, Germany), or both cytokines combined. After
overnight culture surface antigen expression was determined by FACS
analysis. Untreated HDMEC served as controls.
Surface molecule expression in HDMEC exposed to g-irradiated
PBMC In one set of experiments designed to rule out allogeneic effects
of PBMC on surface antigen expression, HDMEC were exposed 1 h to g-
irradiated (30 Gy) PBMC, both HSV-1 infected and noninfected. Surface
molecule expression was determined after overnight culture.
Antibodies Antibodies for the following surface molecules were used:
anti-PECAM-1 (CD31, Harlan Sera-Lab, Loughborough, U.K., diluted
1:40), anti-ICAM-1 (CD54, clone 6.5B5, Dako, diluted 1:50), and anti
HLA class I (clone W6/32 from ATCC, diluted 1:2). TIB 191 (IgG1,
diluted 1:2) and TIB 111 (IgG2a, both from ATCC, diluted 1:2) antibodies
were used as isotype controls. FITC-conjugated rabbit antimouse
immunoglobulin (Dako, diluted 1:40) served as secondary antibody.
Antibodies were diluted in 1% bovine serum albumin in PBS for unspeci®c
blocking.
Northern blot analysis Total RNA was extracted from 5 3 106 cells by
the RNeasy kit (Qiagen, Valencia, CA). 28S and 18S ribosomal RNA were
separated by electrophoresis on a denaturating 1% agarose gel containing
formaldehyde and blotted overnight onto nylon membranes (Zetabind,
CUNO Laboratory Products) according to standard protocols. For
PECAM-1 and HLA-B7 hybridization 5 mg (15 mg for HDMEC infected
with HSV-1), and for ICAM-1 hybridization 8 mg of total RNA were
loaded on the gel. RNA was crosslinked to the membranes by UV light.
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Filters were prehybridized in NaPO4-blocking buffer containing 7%
sodium dodecyl sulfate (SDS) and 1% bovine serum albumin at 65°C for
3 h and hybridized for another 12 h to heat-denatured cDNA probes of
PECAM-1 (a 1800 bp insert of PECAM-1 cloned in the plasmid ptz18R
from Pharmacia, kindly provided by Dr. P. Newman, Blood Research
Institute, Milwaukee, WI), HLA-B7 (ATCC no. 57475, Sood et al, 1981),
and ICAM-1 (a 3000 bp insert of ICAM-1 cloned in the plasmid pCDM8,
kindly provided by Dr. Nancy Hogg, Imperial Cancer Fund, London,
U.K.). For control hybridization a 1950 bp insert cloned in the SP65 vector
(Grummt and Gross, 1980) was used, which is speci®c for mouse 18S
ribosomal RNA. The probes were labeled with a-32P dATP (1 3 107 cpm
per mg) using a random priming DNA labeling kit from Boehringer
Mannheim. After hybridization blots were washed in 1 3 SSPE/0.1% SDS
at 65°C and in 0.1% 3 SSPE/0.1% SDS at 65°C and exposed to an Agfa
Curix X-ray ®lm with an amplifying screen at ±90°C for several hours to
days. After each hybridization the blots were stripped by boiling in 0.1%
SDS.
Adhesion assay PBMC adhesion to endothelial cells was measured with
a luminescence assay (BioLite Luminescent Assay Kit, Packard BioScience,
Groningen, The Netherlands). HMEC-1 (1.5 3 104) were grown to
con¯uence in microtiter plates (View Plate, Packard). PBMC, isolated and
infected with HSV-1 as described above, were cultured in RPMI 1640
without phenol red (Sigma) to avoid interference with luminescence
measurements and labeled according to the manufacturer's instructions.
HMEC-1 cultures were incubated with 2 3 105 PBMC for 1 h at 37°C.
After removal of nonadherent cells by washing with PBS, luminescence
(LumiCount, Packard) of bound PBMC was measured (Iida et al, 1992).
RESULTS
Effect of direct HSV-1 infection of HDMEC by native HSV-
1 on surface expression of CD31, CD54, and MHC class I
molecules
Ef®ciency of infection HDMEC infected with native HSV-1
showed cytopathic effects with characteristic plaques (i.e., defects
of the monolayer due to cell lysis) surrounded by rounded
HDMEC in 60%±90% (Fig 1D), whereas both noninfected cells
and HDMEC exposed to UV-C inactivated HSV-1 (not shown)
remained unaffected (Fig 1C, D). Addition of cytokines (see
below) did not inhibit HSV-1 induced cytopathic effects of
HDMEC monolayers. In infected cultures, 60% and 90% of the
cells proved infected by direct immuno¯uorescence, compared
with 0% in control HDMEC. Infected HDMEC stained with
polyclonal anti-HSV-1 antibody in FACS analyses (Fig 1A),
whereas both noninfected HDMEC and HDMEC exposed to
inactivated virus were negative (Fig 1A, B).
Surface antigen expression Sixteen hours after exposure to virus
supernatants, HLA class I molecules were signi®cantly down-
regulated compared with noninfected HDMEC and HDMEC
exposed to inactivated HSV-1. Similarly, surface expression of
PECAM-1 (CD31) was decreased in infected HDMEC, whereas
ICAM-1 (CD54) expression remained unchanged (Fig 2).
Interestingly, PECAM-1 (CD31) and HLA class I expression were
transiently increased 1 h after infection but began to decline at 3 h,
well before cytopathic effects became discernible, reaching a
minimum at 16±20 h after infection (data not shown).
Effects of cytokines on surface antigen expression Overnight incubation
with IFN-g or IFN-g + TNF-a induced an upregulation of ICAM-
1 and HLA class I in both noninfected and infected HDMEC,
whereas PECAM-1 expression remained unchanged. TNF-a alone
led to only minor changes in HSV-1 infected HDMEC in
expression of these molecules, compared with noninfected
HDMEC (data not shown).
Effect of indirect HSV-1 infection of HDMEC by HSV-1
infected PBMC on surface expression of CD31, CD54, and
MHC class I molecules
Subpopulation analysis of HSV-1 infected PBMC Double ¯uores-
cence staining of HSV-1 infected PBMC revealed 80% of CD14-
positive monocytes reactive with anti-HSV-1 antibody, but only
20% of CD3-positive T cells and 30% of CD19-positive B cells
(Fig 3).
Surface antigen expression of HSV-1 infected PBMC Infection of
PBMC with native HSV-1 resulted in a downregulation of ICAM-
1 (CD54) expression on monocytes, whereas HLA class I antigens
were upregulated and CD31 expression remained unchanged.
Monocytes exposed to inactivated HSV-1 did not show such
alterations (data not shown). HSV-1 infected B and T lymphocytes
did not show any aberrant surface antigen expression (data not
shown).
Ef®ciency of HSV-1 infection of HDMEC via infected PBMC HDMEC
infected via HSV-1 infected PBMC (Fig 4, right) exhibited
characteristic but less marked cytopathic effects as described above,
whereas these effects were absent in HDMEC incubated both with
Figure 1. Morphology of HSV-1 infected HDMEC. HDMEC were
infected with HSV-1 at a multiplicity of infection of 50±100 for 1 h. After
overnight culture 60%±90% of cells showed cytopathic effects. (D) Non-
infected control cells. (C) Scale bar: 200 mm. FACS analysis of HSV-1
infected HDMEC. HDMEC were infected with native (A) or UV-C-
inactivated (B) HSV-1 and cultured overnight. Infection of cells was
analyzed by staining with polyclonal anti-HSV-1 antibody (fat lines).
Normal serum served as a control (broken lines). Non-infected HDMEC
stained with polyclonal anti-HSV-1 antibody (normal lines) and correspond-
ing control (dotted lines) are shown.
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noninfected PBMC (Fig 4, left) and with PBMC exposed to
inactivated HSV-1. Compared to direct infection, the ef®ciency of
infection was very low as determined by immuno¯uorescence (1%±
3%) and FACS analysis: HDMEC infected via PBMC showed only
weak but clearly positive staining whereas HDMEC incubated with
noninfected PBMC or PBMC exposed to inactivated HSV
(Fig 5A, B) were negative.
Surface antigen expression of HDMEC infected with HSV-1 via
PBMC Surface antigens were strikingly differently expressed than
in directly infected HDMEC: ICAM-1 (CD54) expression was
increased up to 5-fold, HLA class I up to 2-fold of control
HDMEC, whereas PECAM-1 (CD31) expression was equal to
normal cells (Fig 6A, E, C). Incubation of HDMEC with PBMC
exposed to inactivated HSV-1 had no effect on the expression of
any of these molecules (Fig 6B, D, F). HSV-1 infected g-irradiated
PBMC resulted in the same level of surface molecule upregulation
in HDMEC as HSV-1 infected non-irradiated PBMC. Uninfected
PBMC did not lead to an upregulation of adhesion molecules,
irrespective of g irradiation (data not shown).
Figure 2. Surface antigen expression of HSV-
1 infected HDMEC. HDMEC were infected
with native (A, C, E) or UV-C inactivated (B, D,
F) HSV-1. Expression of ICAM-1 (CD54), PE-
CAM-1 (CD31), and HLA class I antigen was
analyzed after overnight culture. Infected
HDMEC (fat lines), isotype control (broken lines);
noninfected HDMEC (normal lines), isotype con-
trol (dotted lines).
Figure 3. Infection rate of HSV-1 infected
PBMC. FACS analysis of PBMC double stained
with FITC-conjugated polyclonal anti-HSV-1
antibody (x axis) and PE-conjugated CD3, CD14,
or CD19 monoclonal antibody, respectively (y
axis). CD14-positive monocytes were predomi-
nantly infected, whereas a smaller percentage of
CD19-positive B cells and CD3-positve T cells
showed staining for HSV-1 (upper right quadrant).
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Northern blot analysis Northern blot analysis revealed that
normal HDMEC abundantly expressed PECAM-1 mRNA.
Sixteen to twenty hours after direct infection with native HSV-1,
PECAM-1 mRNA was markedly downregulated. In contrast,
PECAM-1 mRNA was only slightly downregulated in HDMEC
infected via PBMC. Similarly, HLA class I mRNA was markedly
downregulated 16 h after direct HSV-1 infection. In contrast, both
class I and ICAM-1 mRNAs were upregulated in HDMEC
infected via PBMC. No changes of the mRNA expression of
HLA-class I, PECAM-1, and ICAM-1 molecules were induced in
HDMEC exposed to UV-C inactivated HSV-1 or to PBMC
previously exposed to inactivated virus (Fig 7).
Adhesion of HSV-infected PBMC on HMEC-1 In order to
study whether HSV infection would alter the adhesive properties of
PBMC to endothelial cells we performed adhesion assays. Adhesion
of uninfected PBMC was set equal to 100%. Adhesion of PBMC
infected with native HSV-1 was increased more than 2-fold
(230%); incubation of PBMC with inactivated HSV-1 exhibited a
lesser degree of adhesion (164%).
DISCUSSION
In contrast to SJS/TEN, the target lesions of HAEM are
characterized by edema and a dense dermal in¯ammatory in®ltrate
mainly composed of CD4+ T lymphocytes and monocytes (Paquet
et al, 1997), which are responsible for their wheal-like clinical
appearance. There is also microvascular damage such as endothelial
nuclear and cytoplasmic swelling, vacuolization, and luminal
obliteration of super®cial venules (Tonnesen et al, 1983). It may
be suspected that these phenomena are related to interactions of the
causative principal of HAEM, HSV, with the dermal microvascu-
lature. The goal of this study was to investigate these interactions
using HDMEC as an in vitro model.
We ®rst showed that HDMEC can be infected with great
ef®ciency (> 80%) in vitro directly, i.e., by incubation with HSV-1-
containing media: 16±20 h after inoculation, HDMEC exhibit a
cytopathic effect and stain with anti-HSV-1 antibodies. At the same
time, the infected cells undergo signi®cant alterations of cell surface
adhesion molecule expression: after a transient upregulation of
PECAM-1 (CD31) and HLA class I molecules (1±3 h after
infection), both of these molecules are downregulated (6±16 h
after infection, prior to the appearance of the cytopathic effect).
Neither effect was seen in noninfected cells or cells exposed to UV-
C inactivated virus. The likely explanation for the transient
upregulation is autocrine production by virus infected cells of
cytokines, especially TNF-a. TNF-a can be produced by
endothelial cells (Nilsen et al, 1998), and is known to be capable
of upregulating ICAM-1 (CD54) and HLA class I molecules
(Swerlick et al, 1991; Detmar et al, 1992). The difference in the
transient upregulation of PECAM-1 (CD31) and ICAM-1 (CD54)
may be due to different time courses of surface expression induced
by cytokine incubation. In contrast, downregulation is probably
due to viral host shut-off mechanisms by several gene products
preventing the translocation of peptides (Whitley et al, 1998).
We next asked if the downregulation of surface adhesion
molecules observed in vitro (which should result in a reduced in¯ux
of in¯ammatory cells) is likely to correspond to the in vivo situation
characterized by the presence of plentiful in¯ammatory mediators.
Figure 4. Morphology of HDMEC infected
via PBMC. HDMEC were cultured with HSV-1
infected PBMC for 1 h. After removal of PBMC,
HDMEC were cultured overnight. A few plaques
surrounded by infected HDMEC can be seen
(right). Control cells cultured with noninfected
PBMC (left). Scale bar: 100 mm.
Figure 5. FACS analysis of HDMEC infected
via PBMC. HDMEC were cultured with PBMC
infected with native (A) or inactivated (B) HSV-1
for 1 h and cultured overnight. Infection of cells
was analyzed by staining with polyclonal anti-
HSV-1 antibody (fat lines). Weak staining of
HDMEC cultured with PBMC infected with na-
tive virus indicates that only few endothelial cells
were infected. Normal serum served as a control
(broken lines). HDMEC cultured with noninfected
PBMC stained with polyclonal anti-HSV-1 anti-
body (normal lines) and corresponding control
(dotted lines) are shown for comparison.
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We thus added IFN-g, alone or in combination with TNF-a, to
HDMEC after infection with HSV-1. This treatment abrogated the
downregulation of PECAM-1 (CD31) and class I antigens whereas
the cytopathic effects progressed at the same pace as in infected
cultures without cytokine treatment. This phenomenon may be
explained by recent observations that herpes viruses inhibit
interferon-stimulated antiviral responses such as induction of
MHC class I antigens by blocking multiple levels of interferon
signal transduction (Miller et al, 1999). Therefore addition of
cytokines, like interferons, may counteract the HSV-induced
inhibition of MHC class I expression.
Direct infection of endothelial cells by free virions carried with
the blood stream is not a very likely scenario for the pathogenesis of
HAEM because HSV-1 is not recovered by virus cultures from the
peripheral blood of patients with recurrent herpes simplex (Brice
et al, 1992). Transport within immune complexes has been detected
only once (Kazmierowski and Wuepper, 1978), and thus seems not
to be a regularly used mode. Main means of transport are thought
to be PBMC (Aurelian et al, 1998), which were found to contain
HSV-DNA in over 60% of patients in acute phases of HAEM
(Brice et al, 1994). It has been postulated that PBMC may be
infected by HSV but are permissive for only limited replication
(e.g., the pol gene) because viable HSV has only very rarely been
demonstrated in lesional skin of HAEM and only by using electron
microscopy (Major et al, 1978), whereas HSV-DNA is routinely
detectable (Miura et al, 1992; Brice et al, 1994; Imafuku et al, 1997).
We thus asked which, if any, subpopulations of PBMC can be
infected with HSV-1, and if any such infection may be transmitted
to HDMEC.
Several PBMC subsets, after phytohaemagglutinin stimulation,
proved susceptible to infection with HSV-1 as documented by the
expression of HSV-speci®c glycoproteins on their surfaces in direct
immuno¯uorescence and FACS analysis. The highest rate of
infection was found in monocytic cells (80%), the lowest in T cells
(20%). These data do not prove that monocytes are the exclusive
vehicle for HSV-1; all subsets may be instrumental in the
transportation of HSV material to endothelial cells. Our ®ndings
are in accordance with data provided by other investigators (Bruun
et al, 1998) suggesting that activation or differentiation to speci®c
stages is a prerequisite for PBMC to harbor HSV and permit HSV
replication.
We then asked whether HSV-1 infected PBMC were capable of
transmitting the infection to HDMEC. We chose short-time
cocultivation as a model system because of its obvious similarity to
in vivo conditions. We found that infection of HDMEC did occur,
as documented by cytopathic effects and viral surface glycoprotein
expression in direct immuno¯uorescence and FACS analysis, but
only in very few cells (1%±3%). Yet, in contrast to HDMEC
infected directly by virus-containing supernatants, we observed an
Figure 6. Surface antigen expression of HDMEC infected via
PBMC. HDMEC were cultured with PBMC infected with native (A,
C, E) or UV-inactivated (B, D, F) HSV-1. Expression of ICAM-1 (CD54),
PECAM-1 (CD31), and HLA class I antigen was analyzed after overnight
culture. HDMEC cultured with infected PBMC (fat lines), isotype control
(broken lines); HDMEC cultured with noninfected PBMC (normal lines),
isotype control (dotted lines).
Figure 7. HSV-1 induced changes of adhesion molecules on
HDMEC at the mRNA level. Northern blot analysis of total RNA
from noninfected HDMEC (lanes 1) or HDMEC infected with inactivated
HSV-1 (lanes 2), native HSV-1 (lanes 3), or cocultured with PBMC that
were either noninfected (lanes 4) or infected with inactivated (lanes 5) or
native HSV-1 (lanes 6), respectively. mRNAs hybridized with 32P-labeled
cDNA probes for PECAM-1, HLA-B7, and ICAM-1 are shown in the top
panels, control hybridization with the 18S ribosomal RNA in the middle
panels. In the bottom panels the agarose gels stained with ethidium bromide
are shown as loading controls. The 28S and 18S RNAs contained in the
different RNA preparations are visible.
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enormous concomitant upregulation of ICAM-1 (CD54) and HLA
class I surface molecules that was clearly derived from the great
majority of uninfected HDMEC. Upregulation was preceded by an
increase of CD54 and HLA class I mRNA levels. This upregulation
of surface molecule expression was linked to active HSV-1
infection of PBMC as PBMC exposed to UV-C inactivated
HSV-1 showed no such effect; it could not be attributed to
allogeneic effects of the PBMC used in our experiments because
the results were equal for HSV-1 infected PBMC, g irradiated or
not, and there was no adhesion molecule upregulation triggered by
control PBMC, irradiated or not.
As a last question we asked whether HSV-1 infected PBMC,
being capable of inducing adhesion molecule upregulation in
HDMEC, do exhibit an increased binding af®nity to endothelial
cells in vitro. Using HMEC-1 cells as a model system due their
increased adhesiveness in culture ¯asks compared with HDMEC,
we found that this is indeed the case. We speculate that the
increased binding may involve other adhesion molecules as well,
particularly as ICAM-1 (CD54) was downregulated in HSV-1
infected PBMC.
The data presented above lend further evidence for the pivotal
role of HSV-1 infected PBMC in the pathogenesis of HAEM.
HSV-1 infected PBMC not only adhere much more ef®ciently to
endothelial cells but also induce these to upregulate their adhesion
molecule and HLA class I synthesis, both at the mRNA and protein
level, thus setting the stage for the dermal in¯ammatory response
characteristic for HAEM (which is absent in SJS/TEN because the
offensive drugs are transported freely and not via PBMC). HSV-1
material is then likely to be set free from decaying PBMC and to
spill over into the Malpighian layers of the epidermis where it gives
rise to a cytotoxic attack on viral antigens expressing keratinocytes.
Our data show that this sequence of events depends on the
presence of HSV replicating PBMC (as proven by the expression of
viral glycoproteins at their cell surfaces), because neither free HSV-
1 virions nor PBMC exposed to inactivated HSV-1 had any such
effects on HDMEC.
The question remains why only relatively few individuals
develop HAEM following episodes of recurrent herpes simplex.
The underlying speci®c predisposition has been linked in several
reports to speci®c HLA types (DR4 and DQw3) (KaÈmpgen et al,
1988; Kokuba et al, 1998). It might be speculated that the HSV-
speci®c T cell response in these subjects is linked to de®cient HSV
clearance at the site of active replication in the skin (Tigges et al,
1992; Posavad et al, 1998) thus facilitating the recruitment of HSV-
loaded PBMC into the blood stream.
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